Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 13;397(10278):952-954.
doi: 10.1016/S0140-6736(21)00370-6. Epub 2021 Feb 11.

SARS-CoV-2 variants and ending the COVID-19 pandemic

Arnaud Fontanet  1 , Brigitte Autran  2 , Bruno Lina  3 , Marie Paule Kieny  4 , Salim S Abdool Karim  5 , Devi Sridhar  6
Affiliations

SARS-CoV-2 variants and ending the COVID-19 pandemic

Arnaud Fontanet et al. Lancet. .
No abstract available

PubMed Disclaimer

References

    1. Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021;384:403–416. - PMC - PubMed
    1. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020;383:2603–2615. - PMC - PubMed
    1. Voysey M, Costa Clemens SA, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2020;397:99–111. - PMC - PubMed
    1. Logunov DY, Dolzhikova IV, Shcheblyaokov DV, et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVIC-19 vaccine: an interim analysis of a randomized controlled phase 3 trial in Russia. Lancet. 2021 doi: 10.1016/S0140-6736(21)00234-8. published online Feb 2. - DOI - PMC - PubMed
    1. Emary KRW, Golubchik T, Aley PK, et al. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 VOC 202012/01 (B.1.1.7) SSRN. 2021 doi: 10.2139/ssrn.3779160. published online Feb 4. - DOI

Substances